ORALE FORMULIERUNG ENTHALTEND SILYBIN

European patent · EP3373945 · In force

Register entry

Publication number
EP3373945
Application number
EP16808920
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Nov 10, 2016
Published
Sep 19, 2018
Granted
Aug 12, 2020
Protection ends at the latest
Nov 9, 2036
Next annual fee due
Nov 30, 2026
IPC classes
A61K 36/28 (2006.01)
A61P 1/16 (2006.01)
Priority
IT UB20155532 12.11.2015
PCT application
PCT/EP2016/077246 10.11.2016
PCT publication
WO2017/081140 18.05.2017
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 8, 2026

    Change

    Published in Swissreg on 08.01.2026

  2. Dec 1, 2024

    Change

    Published in Swissreg on 01.12.2024

  3. Jan 26, 2024

    Change

    Published in Swissreg on 26.01.2024

  4. May 9, 2023

    Address changed

    Representative
    Valipat S.A., c/o BOVARD SA Neuchâtel, Rue des Noyers 11, 2000 Neuchâtel → VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 09.05.2023

  5. Dec 1, 2022

    Change

    Published in Swissreg on 01.12.2022

  6. Oct 27, 2020

    Agent entered

    Representative
    Valipat S.A., c/o BOVARD SA Neuchâtel, Rue des Noyers 11, 2000 Neuchâtel

    Published in Swissreg on 27.10.2020

  7. Aug 12, 2020

    Granted

    Published in Swissreg on 12.08.2020

Parties

Holder

ISTITUTO BIOCHIMICO ITALIANO GIOVANNI LORENZINI S.p.A.

Via Fossignano 2, 04011 Aprilia, IT

Agent

VALIPAT

c/o BOVARD LTD Optingenstrasse 16, 3013 Bern

Inventor

DI MANZANO, Carlo Maria

00046 Grottaferrata, IT

DE IASI, Gianluca

04011 Aprilia, IT

FEOLA, Monica

00040 Castel Gandolfo, IT

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.